Drug
ND 003
ND 003: highest development phase Phase 2, developed by Shenzhen NewDEL Biotech, Co., Ltd. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shenzhen NewDEL Biotech, Co., Ltd
Trials
| Drug | Phase | Indication |
|---|---|---|
| ND-003 Tablets NCT07929948 | Phase 2 | Idiopathic Pulmonary Fibrosis (IPF) |
Latest
No recent events.
Follow ND 003 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.